{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-006547","form_type":"8-K","ticker":"NKTX","cik":"0001787400","company_name":"Nkarta, Inc.","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.319662+00:00","generated_at":"2026-06-26T03:33:35.379365+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nkarta completes $215.5M public offering of 15.3M shares at $15/sh","bullets":["Sold 13.33M firm shares plus 2M option shares at $15.00/sh.","Net proceeds ~$215.5M after underwriting discounts and expenses.","Proceeds to fund NKX101, NKX019 clinical development, preclinical programs, and manufacturing.","Underwriters: Cowen, SVB Securities, Evercore."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-006547","json":"https://secwatch.observer/filing/0000950170-22-006547.json","markdown":"https://secwatch.observer/filing/0000950170-22-006547.md","text":"https://secwatch.observer/filing/0000950170-22-006547.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/0000950170-22-006547-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787400/000095017022006547/nktx-20220428.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:33:35.379365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}